APA-viite

Chen, R., Huang, Y., Quan, J., Liu, J., Wang, H., Billiar, T. R., . . . Tang, D. (2020). HMGB1 as a potential biomarker and therapeutic target for severe COVID-19. Heliyon.

Chicago-tyylinen lähdeviittaus

Chen, Ruochan, et al. "HMGB1 As a Potential Biomarker and Therapeutic Target for Severe COVID-19." Heliyon 2020.

MLA-viite

Chen, Ruochan, et al. "HMGB1 As a Potential Biomarker and Therapeutic Target for Severe COVID-19." Heliyon 2020.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.